Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › enlicitide

enlicitide

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of enlicitide

3 trials tracked of enlicitide: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 5 citations.

3Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 1 2
  1. Phase 3 A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn) Completed · 5 cited
  2. Phase 1 A Study of Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007) Completed
  3. Phase 1 A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030) Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Phase 3 trial of oral PCSK9 inhibitor enlicitide in hypercholesterolemia reports no results
Diabetes & Endocrinology Phase III
Phase 3 trial of oral PCSK9 inhibitor enlicitide in hypercholesterolemia reports no results Can a new pill lower cholesterol as well as existing drugs?
A completed phase 3 randomized controlled trial in 301 adults with hypercholesterolemia compared oral PCSK9 inhibitor enlicitide to ezetimib…
A new cholesterol pill called enlicitide finished its final trial, but the results showing how well it lowers bad cholesterol and its safety…
CT.gov Apr 3, 2026